Browsing by Author "Ghaemi, S. Nassir"

Now showing items 1-4 of 4

    • A 13-Week, Randomized Double-Blind, Placebo-Controlled, Cross-Over Trial of Ziprasidone in Bipolar Spectrum ... 
      Patkar, Ashwin; Pae, Chi-Un; Vohringer Cárdenas, Paul; Mauer, Sivan; Narasimhan, Meera; Dalley, Shannon; Loebel, Antony; Masand, Prakash; Ghaemi, S. Nassir (LIPPINCOTT WILLIAMS & WILKINS, 2015)
      Objective: Features of bipolarity in a major depressive disorder sample were used to define a "bipolar spectrum disorder" population for treatment with a neuroleptic agent, ziprasidone. Methods: Forty-nine acutely ...
    • Antidepressants worsen rapid-cycling course in bipolar depression: A STEP-BD randomized clinical trial 
      El-Mallakh, Rif S.; Vöhringer Cárdenas, Paul; Ostacher, Michael M.; Baldassano, Claudia F.; Holtzman, Niki S.; Whitham, Elizabeth A.; Thommi, Sairah B.; Goodwin, Frederick K.; Ghaemi, S. Nassir (Elsevier, 2015)
      Background: The use of antidepressants in rapid-cycling bipolar disorder has been controversial. We report the first randomized clinical trial with modern antidepressants on this topic. Methods: As part of the Systematic ...
    • Mixed depression: A study of its phenomenology and relation to treatment response 
      Pae, Chi-Un; Vöhringer Cárdenas, Paul Alfred; Holtzman, Niki S.; Thommi, Sairah B.; Patkar, Ashwin; Gilmer, William; Ghaemi, S. Nassir (Elsevier, 2012)
      Background: Mixed depression reflects the occurrence of a major depressive episode with subsyndromal manic symptoms. Not recognized in DSM-IV, it is included in the proposed changes for DSM-5. Observational and cross-sectional ...
    • Polypharmacy as maintenance treatment in bipolar illness: A systematic review 
      Amerio, Andrea; Russo, Daniel; Miletto, Norberto; Aguglia, Andrea; Costanza, Alessandra; Benatti, Beatrice; Odone, Anna; Barroilhet Diez, Sergio Andrés; Brakoulias, Vlasios; Dell’Osso, Bernardo; Serafini, Gianluca; Amore, Mario; Ghaemi, S. Nassir (Wiley, 2021)
      Objectives: Polypharmacy is common in maintenance treatment of bipolar illness, but proof of greater efficacy compared to monotherapy is assumed rather than well known. We systematically reviewed the evidence from the ...